7/22/02
3:08 PM
Page 3
August 2002
by 1.6% as generally high prices stimulated stock rebuilding. The BP Statistical Review of World Energy 2002 is published at www.bp.com/centres/energy.
JACOBS WINS CANADIAN NATURAL RESOURCES DEAL Jacobs Engineering Group’s Canadian subsidiary has secured a contract to support Canadian Natural Resources Ltd’s development of the Horizon Oil Sands Project in Northern Alberta, Canada. Officials estimate the value of the Horizon Oil Sands Project at C$3.4 billion–C$5.1 billion. Jacobs is executing the design work on the support facilities for the bitumen upgrader.
KERR-MCGEE SANCTIONS DEEPWATER GAS DEVELOPMENT Kerr-McGee Corp’s board of directors has approved the development of the Red Hawk area in the deepwater Gulf of Mexico, in Garden Banks block 877. The Red Hawk natural gas field, with estimated proven reserves of more than 250 billion cubic feet of gas, will be developed using a new state-ofthe-art mini-floating production facility. Located in more than 5300 feet of water, Red Hawk will be Kerr-McGee’s deepest development to date. The company is in the final stages of selecting the development solution for the Red Hawk facility, which is being designed to process 120 million cubic feet of gas per day. Facility construction is set to begin in October with development drilling starting in early 2003. First production at Red Hawk is anticipated in the second quarter of 2004.
Filtration Industry Analyst
FW WINS SPANISH UPGRADE FROM BP OIL Foster Wheeler Iberia SA (FW) is to upgrade part of BP Oil Refineria de Castellon SA’s 120 000 barrels per stream day (BPSD) Castellon refinery in Spain to produce ultra-low sulfur fuels in a project valued at around US$100 million. FW will be responsible for the engineering, equipment and material procurement, and construction supervision for the project, which is scheduled for mechanical completion in mid-2004. The project, part of BP’s Ultimate Generation Fuels programme, includes the installation of a new diesel hydrotreater, a hydrogen plant and a naphtha hydrotreater. FW will also revamp the existing distillation, heavy/light gas oil, MEA regeneration and sour water stripper units, as well as the main utilities, including DCS and electricity. The project will be managed by FW with the participation of Technip for the hydrogen plant and utilities.
OIL & GAS MAJORS SIGN CHINESE FRAMEWORK AGREEMENT Shell International Gas Ltd, OAO Gazprom and ExxonMobil China Gas Pipeline Ltd have signed a joint venture framework agreement with PetroChina Co Ltd and China Petroleum and Chemical Corp (Sinopec) for the West East Project. PetroChina is the lead Chinese partner in the project, which involves the upstream development of gas fields in the Tarim Basin, the construction and operation of a 40-inch pipeline from Xinjiang to Shanghai, and the marketing of
gas transported in the pipeline. Shell, Gazprom and ExxonMobil will take an equal 15% share of the integrated project (including gas production). Hong Kong and China Gas and Stroytransgaz will participate in the pipeline project.
PHARMACEUTICALS
The Sandwich complex serves as Pfizer’s headquarters for drug research and development in Europe. When completed, the building, known as B530, will include nearly 390 000 square feet of office space, laboratories and ancillary facilities. Construction began in December 2001, with completion scheduled for summer 2004.
DSM BIOLOGICS TO BUILD NEW PLANT IN MONTREAL
FW EXPANDS GLOBAL PHARMA CAPABILITIES
DSM is investing 7 million in basic engineering for a new biopharmaceutical plant in Montreal, Canada. The multi-product facility will comprise four fermentors with a combined capacity of more than 60 000 litres and will also include downstream processing and all necessary infrastructure. It will be used for the production of monoclonal antibodies and recombinant proteins based on mammalian cell culture technology. The plant will have a modular design, with two production lines of about 30 000 litres each. This makes it possible to adapt or expand the facility depending on the processes to be operated in it and the needs of the market. The new hightech plant represents a largescale expansion of DSM Biologics’ R&D and production facilities in Montreal. DSM’s board is expected to give the final go ahead for the construction of the modular plant later this year.
Foster Wheeler Ltd (FW) has set up Foster Wheeler Global Pharmaceuticals to coordinate and manage FW’s global pharmaceutical activities. The company will conduct business with worldwide pharmaceutical customers and will have the capacity to execute global agreements backed by all FW operating entities. Projects performed by the new company will continue to be executed through the appropriate FW operating centre and the client’s local affiliate.
FLUOR AWARDED PFIZER PROJECT IN THE UK Fluor Ltd has won a US$113 million contract from Pfizer Ltd for the construction management and commissioning of a pharmaceutical development facility in Sandwich, Kent, UK.
PETROCHEMICALS ZIMMER TO BUILD THAI POLYESTER PLANT Germany’s Zimmer AG has been awarded a contract for the construction of a polycondensation plant in Map Ta Phut, Thailand, designed to produce polyester granulate for PET bottles. It will have a capacity of 300 tons per day. The customer is Thai PET Resin Co Ltd, a joint venture of Mitsui Chemicals (70%) and Siam Mitsui PTA Co Ltd (30%). Apart from technology, Zimmer will provide the key equipment and will be responsible for the supervision of
3
MARKET PROSPECTS
FIAAugust.qxd